首页> 外文期刊>Bioorganic and medicinal chemistry >Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
【24h】

Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.

机译:碳酸酐酶抑制剂:用芳香族/杂环磺酰胺库抑制人跨膜同工酶XIV。

获取原文
获取原文并翻译 | 示例
           

摘要

The first inhibition study of the transmembrane carbonic anhydrase (CA, EC 4.2.1.1) isozymes hCA XIV with a library of aromatic and heteroaromatic sulfonamides synthesized earlier is reported. Most of the inhibitors were sulfanilamide, homosulfanilamide and 4-aminoethyl-benzenesulfonamide derivatives, to which tails that would induce diverse physicochemical properties have been attached at the amino moiety. Several of these compounds were metanilamide, benzene-1,3-disulfonamide or the 1,3,4-thiadiazole/thiadiazoline-2-sulfonamide derivatives. The tails incorporated in these molecules were of the alkyl/aryl-carboxamido/ sulfonamido-, ureido- or thioureido-types. The sulfanilamides acylated at the 4-amino group with short aliphatic/aromatic moieties incorporating 2-6 carbon atoms showed modest hCA XIV inhibitory activity (K(I)-s in the range of 1.25-4.2 microM) which were anyhow better than that of sulfanilamide (K(I) of 5.4 microM). Better activity showed the homosulfanilamide and 4-aminoethyl-benzenesulfonamide derivatives bearing arylsulfonamido/ureido and thioureido moieties, with K(I)'s in the range of 203-935 nM. The best activity was observed for the heteroaromatic compounds incorporating 1,3,4-thiadiazole/thiadiazoline-2-sulfonamide and 5-arylcarboxamido/sulfonamido moieties, with K(I)'s in the range of 10-85 nM. All these compounds were generally also much better inhibitors of the other two transmembrane CA isozyme, hCA IX and XII. Thus, highly potent hCA XIV inhibitors were detected, but isozyme-specific inhibitors were not discovered for the moment.
机译:首次报道了跨膜碳酸酐酶(CA,EC 4.2.1.1)同工酶hCA XIV与较早合成的芳族和杂芳族磺酰胺库的抑制作用研究。大多数抑制剂是磺胺,高磺酰胺和4-氨基乙基-苯磺酰胺衍生物,在其氨基部分已连接了诱导多种理化性质的尾巴。这些化合物中的几种是间甲酰胺,苯-1,3-二磺酰胺或1,3,4-噻二唑/噻二唑啉-2-磺酰胺衍生物。掺入这些分子的尾巴为烷基/芳基-甲酰胺基/磺酰胺基-,脲基或硫脲基-型。在4-氨基处被短的脂族/芳族基团与2-6个碳原子酰化的磺酰苯胺显示出适度的hCA XIV抑制活性(K(I)-s在1.25-4.2 microM范围内),无论如何都优于磺胺(K(I)为5.4 microM)。更好的活性显示带有芳基磺酰胺基/脲基和硫脲基的高磺胺和4-氨基乙基-苯磺酰胺衍生物,K(I)在203-935 nM范围内。对于掺入1,3,4-噻二唑/噻二唑啉-2-磺酰胺和5-芳基羧酰胺基/磺酰胺基部分的杂芳族化合物,观察到最佳活性,其K(I)在10-85nM的范围内。所有这些化合物通常还是其他两种跨膜CA同工酶hCA IX和XII的更好抑制剂。因此,检测到了高效的hCA XIV抑制剂,但目前尚未发现同工酶特异性抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号